Package 50090-2102-0

{"route": ["ORAL"], "spl_id": "5c0321da-e5aa-4817-bf12-3212f9becaa0", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "unii": ["0H73WJJ391"], "rxcui": ["151226", "199888", "199889"], "spl_set_id": ["a5cffe7a-fdee-487a-bafb-a2d43e76c23c"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (50090-2102-0)", "package_ndc": "50090-2102-0", "marketing_start_date": "20151013"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (50090-2102-1)", "package_ndc": "50090-2102-1", "marketing_start_date": "20151013"}, {"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (50090-2102-2)", "package_ndc": "50090-2102-2", "marketing_start_date": "20151013"}], "brand_name": "topiramate", "product_id": "50090-2102_5c0321da-e5aa-4817-bf12-3212f9becaa0", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "50090-2102", "generic_name": "topiramate", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "25 mg/1"}], "application_number": "ANDA090162", "marketing_category": "ANDA", "marketing_start_date": "20130701", "listing_expiration_date": "20261231"}